Sterne Kessler’s Matthew Bodenstein and Daniel Choo moderated the KnowledgeBridge Breakout Session titled “Biopharma Patents During the Post-Amgen Era” at the 2025 IP Life Sciences Forum hosted by Consero. The breakout session discussed specification (breadth & support), claim strategy (fate of genus and functional claims), and global coordination (e.g., EPO and China comparisons).

The firm was also a conference sponsor.

Related Industries